Progression of non-significant mitral and tricuspid regurgitation after surgical aortic valve replacement for aortic regurgitation

Back

ESC Professional Premium Access

Progression of non-significant mitral and tricuspid regurgitation after surgical aortic valve replacement for aortic regurgitation

Session: New insights around surgical valve replacement

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor S. Kazum (Petah Tikva, IL)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Shirit Kazum

Rabin Medical Center, Petah Tikva (Israel)

1 presentation

0 follower

6 more presentations in this session

Biological versus mechanical SAVR patient's age threshold: PARTNER II study influenced real world practice in a large French cohort.

Speaker: Doctor Y. Chabry (Paris, FR)

Three-year outcomes following transcatheter versus surgical aortic valve replacement in younger, low surgical risk patients with severe aortic stenosis

Speaker: Professor T. Modine (Bordeaux, FR) Professor N. van Mieghem (Rotterdam, NL)

Predictors of major adverse cardiovascular events in patients with severe aortic stenosis awaiting aortic valve replacement

Speaker: Doctor I. Fialho (Lisbon, PT)

Early mitral valve repair surgery versus active surveillance in patients with asymptomatic severe primary mitral regurgitation; insights from the Dutch AMR registry

Speaker: Doctor S. El Mathari (Amsterdam, NL)

Elderly patients with severe aortic stenosis - does moderate mitral regurgitation require simultaneous surgical intervention?

Speaker: Doctor A. Kwiecien (Zabrze, PL)

Access the full session

New insights around surgical valve replacement

Speakers: Doctor S. Kazum, Doctor Y. Chabry, Professor T. Modine, Professor N. van Mieghem, Doctor I. Fialho...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources